{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:05:04Z","timestamp":1791068704836,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.dld.2015.07.156","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T01:04:08Z","timestamp":1438823048000},"page":"957-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5358-5426","authenticated-orcid":false,"given":"Priscila","family":"Pollo-Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica","family":"Soldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubiratan Cassano","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Gobbi","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Espindola","family":"Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Cerqueira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Cabral","family":"Marchiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2235-2296","authenticated-orcid":false,"given":"Guilherme Ferreira da Motta","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2015.07.156_bib0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-2006-951603","article-title":"Measurement of portal pressure and its role in the management of chronic liver disease","volume":"26","author":"Bosch","year":"2006","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/j.dld.2015.07.156_bib0185","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01320309","article-title":"Survival and prognostic indicators in compensated and decompensated cirrhosis","volume":"31","author":"D\u2019Amico","year":"1986","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.dld.2015.07.156_bib0190","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review","volume":"131","author":"D\u2019Amico","year":"2006","journal-title":"Gastroenterology"},{"issue":"Suppl. 3","key":"10.1016\/j.dld.2015.07.156_bib0195","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1097\/MCG.0b013e318150d0f4","article-title":"Hepatic venous pressure gradient and outcomes in cirrhosis","volume":"41","author":"Ripoll","year":"2007","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2015.07.156_bib0200","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"issue":"Suppl. 3","key":"10.1016\/j.dld.2015.07.156_bib0205","doi-asserted-by":"crossref","first-page":"S300","DOI":"10.1097\/MCG.0b013e318157c63d","article-title":"Preventing the development of varices in cirrhosis","volume":"41","author":"Garcia-Tsao","year":"2007","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2015.07.156_bib0210","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2015.07.156_bib0215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0140-6736(90)91668-Z","article-title":"Meta-analysis of value of propranolol in prevention of variceal haemorrhage","volume":"336","author":"Hayes","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2015.07.156_bib0220","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"Reiberger","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.07.156_bib0225","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2007.01191.x","article-title":"Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis","volume":"102","author":"Albillos","year":"2007","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.07.156_bib0230","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","article-title":"Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial","volume":"136","author":"Abraldes","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.07.156_bib0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0016-5107(99)70343-3","article-title":"Use of color Doppler EUS in assessing azygos blood flow for patients with portal hypertension","volume":"50","author":"Lee","year":"1999","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1016\/j.dld.2015.07.156_bib0240","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0016-5107(03)02544-6","article-title":"EUS-guided portal vein catheterization and pressure measurement in an animal model: a pilot study of feasibility","volume":"59","author":"Lai","year":"2004","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1016\/j.dld.2015.07.156_bib0245","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/003655201750074717","article-title":"Endoscopic Doppler ultrasound for measurement of azygos blood flow. Validation against thermodilution and assessment of pharmacological effects of terlipressin in portal hypertension","volume":"36","author":"Hansen","year":"2001","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.07.156_bib0250","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/hep.23045","article-title":"Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed","volume":"50","author":"Tripathi","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0255","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2036.2001.00920.x","article-title":"Review article: a drug therapy for the prevention of variceal haemorrhage","volume":"15","author":"Tripathi","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.07.156_bib0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1478-3231.2011.02579.x","article-title":"Endothelial dysfunction in the regulation of cirrhosis and portal hypertension","volume":"32","author":"Iwakiri","year":"2012","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2015.07.156_bib0265","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2174\/157016112803520918","article-title":"Statins and portal hypertension: a new pharmacological challenge","volume":"10","author":"Ramirez","year":"2012","journal-title":"Current Vascular Pharmacology"},{"key":"10.1016\/j.dld.2015.07.156_bib0270","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2007.01.020","article-title":"Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats","volume":"46","author":"Abraldes","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0275","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial NO synthase","volume":"46","author":"Trebicka","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0280","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","article-title":"Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells","volume":"53","author":"Trebicka","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0285","first-page":"95","article-title":"Future therapy of portal hypertension in liver cirrhosis \u2013 a guess","volume":"6","author":"Sauerbruch","year":"2014","journal-title":"F1000 Prime Reports"},{"key":"10.1016\/j.dld.2015.07.156_bib0290","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1440-1746.2009.06159.x","article-title":"Simvastatin effects on portal-systemic collaterals of portal hypertensive rats","volume":"25","author":"Huang","year":"2010","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0295","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0300","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0168-8278(98)80351-6","article-title":"Clinical vs haemodynamic response to drugs in portal hypertension","volume":"28","author":"McCormick","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0305","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cld.2006.08.005","article-title":"Measurement of portal pressure: when, how, and why to do it","volume":"10","author":"Groszmann","year":"2006","journal-title":"Clinics in Liver Disease"},{"key":"10.1016\/j.dld.2015.07.156_bib0310","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2012.08.026","article-title":"The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins","volume":"58","author":"Marrone","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0315","series-title":"Addition of simvastatin to standard treatment improves survival after variceal bleeding in patients with cirrhosis. A double-blind randomized trial (NCT01095185)","author":"Abraldes","year":"2014"},{"key":"10.1016\/j.dld.2015.07.156_bib0320","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0325","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.07.156_bib0330","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/j.1440-1746.2012.07232.x","article-title":"Potential for statins in the chemoprevention and management of hepatocellular carcinoma","volume":"27","author":"Lonardo","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0335","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.27157","article-title":"Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network","volume":"60","author":"Russo","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0340","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2011.07.023","article-title":"Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing","volume":"56","author":"Bjornsson","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0345","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0168-8278(85)80761-3","article-title":"Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients","volume":"1","author":"Bosch","year":"1985","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.07.156_bib0350","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/00365520500463290","article-title":"Circadian rhythm of fasting and postprandial portal blood flow in cirrhosis","volume":"41","author":"Schiedermaier","year":"2006","journal-title":"Scandinavian Journal of Gastroenterology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815005629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815005629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T07:56:30Z","timestamp":1537430190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865815005629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1590865815005629"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2015.07.156","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2015.07.156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}